These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10942856)

  • 1. Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study.
    Zubieta J; Greenwald MK; Lombardi U; Woods JH; Kilbourn MR; Jewett DM; Koeppe RA; Schuster CR; Johanson CE
    Neuropsychopharmacology; 2000 Sep; 23(3):326-34. PubMed ID: 10942856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers.
    Greenwald MK; Johanson CE; Moody DE; Woods JH; Kilbourn MR; Koeppe RA; Schuster CR; Zubieta JK
    Neuropsychopharmacology; 2003 Nov; 28(11):2000-9. PubMed ID: 12902992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices.
    Greenwald M; Johanson CE; Bueller J; Chang Y; Moody DE; Kilbourn M; Koeppe R; Zubieta JK
    Biol Psychiatry; 2007 Jan; 61(1):101-10. PubMed ID: 16950210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy.
    Greenwald MK; Comer SD; Fiellin DA
    Drug Alcohol Depend; 2014 Nov; 144():1-11. PubMed ID: 25179217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers.
    Comer SD; Collins ED
    J Pharmacol Exp Ther; 2002 Nov; 303(2):695-703. PubMed ID: 12388653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of buprenorphine on fentanyl withdrawal in rats.
    Bruijnzeel AW; Marcinkiewcz C; Isaac S; Booth MM; Dennis DM; Gold MS
    Psychopharmacology (Berl); 2007 May; 191(4):931-41. PubMed ID: 17211652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.
    Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA
    Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
    Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC
    Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu-opioid self-administration vs passive administration in heroin abusers produces differential EEG activation.
    Greenwald MK; Roehrs TA
    Neuropsychopharmacology; 2005 Jan; 30(1):212-21. PubMed ID: 15508021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers.
    Walsh SL; Nuzzo PA; Babalonis S; Casselton V; Lofwall MR
    Drug Alcohol Depend; 2016 May; 162():190-8. PubMed ID: 27012435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers.
    Comer SD; Walker EA; Collins ED
    Psychopharmacology (Berl); 2005 Oct; 181(4):664-75. PubMed ID: 16025322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine.
    Upadhyay J; Anderson J; Baumgartner R; Coimbra A; Schwarz AJ; Pendse G; Wallin D; Nutile L; Bishop J; George E; Elman I; Sunkaraneni S; Maier G; Iyengar S; Evelhoch JL; Bleakman D; Hargreaves R; Becerra L; Borsook D
    Neuroimage; 2012 Feb; 59(4):3762-73. PubMed ID: 22119647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain.
    Martin TJ; Kahn WR; Xiao R; Childers SR
    Synapse; 2007 Mar; 61(3):176-84. PubMed ID: 17152089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study.
    Threlkeld M; Parran TV; Adelman CA; Grey SF; Yu J
    Am J Addict; 2006; 15(2):186-91. PubMed ID: 16595358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance.
    Greenwald MK; Johanson CE; Schuster CR
    Drug Alcohol Depend; 1999 Oct; 56(3):191-203. PubMed ID: 10529021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl Use.
    Hailozian C; Luftig J; Liang A; Outhay M; Ullal M; Anderson ES; Kalmin M; Shoptaw S; Greenwald MK; Herring AA
    J Addict Med; 2022 Jul-Aug 01; 16(4):483-487. PubMed ID: 34789683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration.
    Maher CE; Martin TJ; Childers SR
    Life Sci; 2005 Jul; 77(10):1140-54. PubMed ID: 15890372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ
    Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.